simendan has been researched along with Hypertrophy, Left Ventricular in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andersson, KB; Christensen, G; Golz, S; Hillestad, V; Knorr, A; Kramer, F | 1 |
Bhavsar, R; Frederiksen, CA; Jakobsen, CJ; Juhl-Olsen, P; Klaaborg, KE; Rasmussen, LA; Sloth, E | 1 |
Bech-Hanssen, O; Houltz, E; Jörgensen, K; Ricksten, SE | 1 |
2 trial(s) available for simendan and Hypertrophy, Left Ventricular
Article | Year |
---|---|
Effects of levosimendan in patients with left ventricular hypertrophy undergoing aortic valve replacement.
Topics: Aged; Aged, 80 and over; Aortic Valve; Double-Blind Method; Echocardiography; Female; Heart Valve Prosthesis Implantation; Hemodynamics; Humans; Hydrazones; Hypertrophy, Left Ventricular; Male; Middle Aged; Prospective Studies; Pyridazines; Simendan | 2015 |
Effects of levosimendan on left ventricular relaxation and early filling at maintained preload and afterload conditions after aortic valve replacement for aortic stenosis.
Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Blood Pressure; Cardiotonic Agents; Diastole; Echocardiography; Female; Heart Valve Prosthesis Implantation; Humans; Hydrazones; Hypertrophy, Left Ventricular; Male; Mitral Valve; Pyridazines; Simendan; Stroke Volume; Treatment Outcome; Vascular Resistance; Ventricular Function, Left | 2008 |
1 other study(ies) available for simendan and Hypertrophy, Left Ventricular
Article | Year |
---|---|
Long-term levosimendan treatment improves systolic function and myocardial relaxation in mice with cardiomyocyte-specific disruption of the Serca2 gene.
Topics: Animals; Calcium Signaling; Cardiotonic Agents; Diastole; Disease Models, Animal; Extracellular Matrix Proteins; Fibrosis; Gene Expression Regulation; Heart Failure; Hydrazones; Hypertrophy, Left Ventricular; Mice; Mice, Knockout; Myocytes, Cardiac; Pyridazines; Recovery of Function; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Simendan; Stroke Volume; Systole; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Pressure | 2013 |